FBONX | TASHX | FBONX / TASHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 11 years | - |
Gain YTD | 15.358 | 14.185 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 238B | 719M | 33,102% |
Annual Yield % from dividends | 2.50 | 3.80 | 66% |
Returns for 1 year | 28.11 | 23.88 | 118% |
Returns for 3 years | 15.74 | 13.04 | 121% |
Returns for 5 years | N/A | 46.22 | - |
Returns for 10 years | N/A | 87.87 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 27.20 | -0.01 | -0.04% |
iShares Neuroscience and Healthcare ETF | |||
DIVZ | 33.36 | -0.25 | -0.74% |
Opal Dividend Income ETF | |||
NUMG | 45.59 | -0.58 | -1.26% |
Nuveen ESG Mid-Cap Growth ETF | |||
PP | 27.36 | -0.50 | -1.79% |
The Meet Kevin Pricing Power ETF | |||
DES | 34.40 | -0.76 | -2.16% |
WisdomTree US SmallCap Dividend ETF |